メタボリックシンドロームによる妊娠中の心臓改造: 病理的な改造の序章
Yijun Yang1, Justin Kurian2, Giana Schena1
1Independence Blue Cross Cardiovascular Research Center and Department of Physiology (Y.Y., G.S., J.J., H.K., D.M.E., S.R.H.).
Circulation
|February 15, 2021
まとめ
メタボリックシンドローム (MetS) は,妊娠に関連した正常な心臓の成長を妨害し,肥満の女性では病的な心臓の改造と心血管疾患のリスクを高めます. この研究では,これらの有害な心臓変化を動物モデルで調査した.
科学分野:
- 心血管の生理学
- 生殖生物学
- 代謝障害
背景:
- メタボリックシンドローム (MetS) は,出産年齢の女性においてますます一般的です.
- 妊娠は通常,生理学的心縮を誘発する.
- MetSは妊娠中に心血管疾患のリスクを増やす可能性があります.
研究 の 目的:
- 肥満の妊婦のメタボリック・スチロール症候群の異常を調査する.
- MetSが妊娠中に心血管疾患を誘発するかどうかを判断する.
主な方法:
- 15週間の西洋ダイエット (WD) の動物モデルで,ヒトのMetSを模倣した.
- 妊娠したマウスとWD誘発のMetSの比較 (妊娠したマウスと妊娠していないマウス).
主要な成果:
- WD誘発のMetSを患った妊娠マウスは,心臓の質量増加,線維症,胎児の遺伝子上昇を示した.
- 異なる遺伝子発現プロファイルが,METSの心臓で観察されました.
- MetSマウスは出産後に心臓の過剰成長と機能不全を示した.
結論:
- 妊娠中の生理学的な高縮を病理的な改造に変えることができます.
- この病理的な改造は慢性的な心血管疾患への感受性を高める可能性があります.
関連する概念動画
Cardiomyopathy III: Hypertrophic Cardiomyopathy
146
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
146
Heart Failure II: Pathophysiology
217
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
217
Mitral Valve Prolapse III: Nursing Management
127
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
127
Pathophysiology of Diabetes
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.4K
Cardiomyopathy V: Interprofessional Care
121
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
121
Cardiomyopathy II: Dilated Cardiomyopathy
147
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
147


